Savill Pharmalabs Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 11-01-2025
- Paid Up Capital ₹ 2.00 M
as on 11-01-2025
- Company Age 38 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.12 Cr
as on 11-01-2025
- Revenue -2.57%
(FY 2020)
- Profit -19.01%
(FY 2020)
- Ebitda 25.23%
(FY 2020)
- Net Worth 11.26%
(FY 2020)
- Total Assets -7.42%
(FY 2020)
About Savill Pharmalabs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company has closed loans amounting to ₹3.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Devendra Punamchand, Jain Krutik, Punit Jayantilal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1986PTC038968
- Company No.
038968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 1986
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Savill Pharmalabs Pvt Ltd offer?
Savill Pharmalabs Pvt Ltd offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Cardiovascular Drugs & Medication, Cardiac Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Antispasmodic Drugs, Antibacterial Drugs.
Who are the key members and board of directors at Savill Pharmalabs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devendra Punamchand  | Director | 29-Sep-2001 | Current |
| Jain Krutik | Director | 02-Jan-2017 | Current |
| Punit Jayantilal | Director | 02-Jan-2017 | Current |
| Jayantilal Jain | Director | 17-Feb-1986 | Current |
Financial Performance of Savill Pharmalabs.
Savill Pharmalabs Pvt Ltd, for the financial year ended 2020, experienced Minor drop in revenue, with a 2.57% decrease. The company also saw a substantial fall in profitability, with a 19.01% decrease in profit. The company's net worth Soared by an impressive increase of 11.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Savill Pharmalabs?
In 2020, Savill Pharmalabs had a promoter holding of 50.40% and a public holding of 49.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jan 2018 | ₹1.80 Cr | Satisfied |
Bank Of Baroda Creation Date: 26 Feb 2006 | ₹6.00 M | Satisfied |
Bank Of Baroda Creation Date: 16 Feb 2006 | ₹6.00 M | Satisfied |
How Many Employees Work at Savill Pharmalabs?
Unlock and access historical data on people associated with Savill Pharmalabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Savill Pharmalabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Savill Pharmalabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
